GE Healthcare To Market India-Developed Portable Heart Monitor
This article was originally published in PharmAsia News
GE Healthcare's seven-pound MAC 800 heart monitor, which it expects to market in the United States, was the result not of U.S. technology, but of engineers in China and India. The company has been expanding its engineering staff in those countries for just over a decade. Indian engineers developed the MAC 800's forerunner as part of an effort to make a portable diagnostic that Indian physicians could carry into rural villages. The result was a device only a fifth of the size of existing monitors, and is to be marketed in the U.S. by GE for $2,500. (Click here for more
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.